Public annual accounts

Apotheek Olyslager-Snoeckx financials

Name: Apotheek Olyslager-Snoeckx financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Apotheek Olyslager-Snoeckx, with comparable measures and links to available source documents.

Company overview

Registry number

0899590569

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Apotheek Olyslager-Snoeckx

2025 versus 2024

Operating line: €1,731,321
EBITDA: €1,030,390
Total assets: €4,902,332
Equity: €2,023,552

EBITDA margin +59.5% · Equity ratio +41.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€1,731,321	€1,030,390	€4,902,332	€2,023,552	-
202431 Dec 2024	€1,701,876	€1,076,790	€4,779,558	€1,935,282	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€1,731,321

€1,030,390

€4,902,332

€2,023,552

202431 Dec 2024

€1,701,876

€1,076,790

€4,779,558

€1,935,282